Multiple Sclerosis & Myasthenia Gravis Meds

Question 1

General Info About Multiple Sclerosis

Answer 1

Question 2

Risk Factors and Classifications of MS

Answer 2

Question 3

Treatment of Multiple Sclerosis: Acute Attacks and Supportive Care

Answer 3

Question 4

Treatment Recommendations of Multiple Sclerosis

Answer 4

Question 5

Disease Modifying Treatments for Multiple Sclerosis: Oral Meds Overview

Answer 5

Question 6

Fingolimod (Gilenya) and Other Meds

Answer 6

Question 7

Dimethyl Fumarate & Teriflunomide

Answer 7

Question 8

Cladribine (Mavenclad)

Answer 8

Question 9

Summary Table of Moderately Effective PO Treatment of MS

Answer 9

Question 10

Modestly Effective Treatment of MS: Injectables Overview

Answer 10

Question 11

Interferon Beta 1a and 1b Meds

Answer 11

Question 12

Glatiramer Acetate (Copaxone)

Answer 12

Question 13

1st line Modestly Effective Tx of Multiple Sclerosis Chart

Answer 13

Question 14

Highly Effective Tx of RMS & PPMS: Overview

Answer 14

Question 15

Alemtuzumab (Lemtrada)

Answer 15

Question 16

Drugs that Target CD20

Answer 16

Question 17

Natalizumab (Tysabri)

Answer 17

Question 18

Mitoxantrone (Novantrone)

Answer 18

Question 19

Highly Effective Tx of RMS & PPMS

Answer 19

Question 20

Additional Txs for Multiple Sclerosis Refractory to other Txs

Answer 20

Question 21

Tx Summary for Multiple Sclerosis

Answer 21

Question 22

Dalfampridine (Ampyra)

Answer 22

Question 23

Pathophys of Myasthenia Gravis

Answer 23

Question 24

Clinical Presentation of Myasthenia Gravis

Answer 24

Question 25

Drugs to Avoid in Myasthenia Gravis

Answer 25

Question 26

Diagnostic Tests for Myasthenia Gravis

Answer 26

Question 27

Treatment Algorithm for Myasthenia Gravis

Answer 27

Question 28

Myasthenia Gravis Meds Overview

Answer 28

Question 29

AChE Inhibitors

Answer 29